JAMIA Publication:The Potential and Pitfalls of using a LLM as a Clinical Assistant

Predicting Length-of-Stay & Risk of Mortality for ICU Patients

Pangaea Data Awarded Top Tier Co-Sell Partnership Status by Microsoft

Pangaea Named ‘Digital Solution of the Year’ by UK Government’s Department for International Trade

WHITEPAPER: How can Pharmaceutical & Healthcare Providers Collaborate in a Financially Sustainable & Scalable Manner to Improve Patient Outcomes?
Go back

Pharmaceutical Success Stories

Breakthrough AI to Characterize Hard to Diagnose Conditions to Find More Patients and Auto-Generate Regulatory Reports 

Tuesday, November 16th at 12:00 PM EST (9:00 AM PT/ 5:00 PM GMT) 

Hear from Dr. Rick Sax, former SVP at IQVIA, AstraZeneca and Merck, on how pharmaceutical companies are applying Pangaea’s novel AI for characterizing hard to diagnose diseases to find 95% more patients, improve screening success rates by 400% and save 80-90% time by automatically generating clinical narratives for regulatory reports.

Request Recording

Speakers

Dr. Rick Sax
Former SVP at IQVIA, AstraZeneca and Merck
Mr. Jingqing Zhang
Head of AI
Pangaea Data

You have successfuly subscribed!